Subclinical Cushing Syndrome: A Review

Surgical Clinics of North America

Volumn 94, Issue 3, 2014, Pages 657-668

  Starker, Lee F ^a   Kunstman, John W ^a   Carling, Tobias ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenal incidentalomas; Corticotropin; Dexamethasone suppressive testing; Subclinical Cushing syndrome

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; PRASTERONE SULFATE;

ADRENAL INCIDENTALOMA; ADRENAL SCINTISCANNING; ADRENAL TUMOR; ADRENALECTOMY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DISORDERS OF STEROID METABOLISM; ENDOCRINOLOGIST; HUMAN; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; PRIORITY JOURNAL; REVIEW; SUBCLINICAL CUSHING SYNDROME; SURGEON; TREATMENT INDICATION;

ADRENAL INCIDENTALOMAS; CORTICOTROPIN; DEXAMETHASONE-SUPPRESSIVE TESTING; SUBCLINICAL CUSHING SYNDROME;

ADRENALECTOMY; CUSHING SYNDROME; DIAGNOSTIC IMAGING; HUMANS; INCIDENTAL FINDINGS;

EID: 84901271611     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2014.02.008     Document Type: Review

References (68)

1. Ross N.S. Epidemiology of Cushing's syndrome and subclinical disease. Endocrinol Metab Clin North Am 1994, 23(3):539-546.
2. Young W.F. Clinical practice. The incidentally discovered adrenal mass. NEngl J Med 2007, 356(6):601-610.
3. Kloos R.T., Korobkin M., Thompson N.W., et al. Incidentally discovered adrenal masses. Cancer Treat Res 1997, 89:263-292.
4. Mantero F., Arnaldi G. Management approaches to adrenal incidentalomas. Aview from Ancona, Italy. Endocrinol Metab Clin North Am 2000, 29(1):107-125. ix.
5. Funder J.W., Carey R.M., Fardella C., et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. JClin Endocrinol Metab 2008, 93(9):3266-3281.
6. Terzolo M., Bovio S., Pia A., et al. Subclinical Cushing's syndrome. Arq Bras Endocrinol Metabol 2007, 51(8):1272-1279.
7. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 2000, 29(1):43-56.
8. Beierwaltes W.H., Sturman M.F., Ryo U., et al. Imaging functional nodules of the adrenal glands with 131-I-19-iodocholesterol. JNucl Med 1974, 15(4):246-251.
9. Charbonnel B., Chatal J.F., Ozanne P. Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist?. JNucl Med 1981, 22(12):1059-1061.
10. McLeod M.K., Thompson N.W., Gross M.D., et al. Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management. Am Surg 1990, 56(7):398-403.
11. Grumbach M.M., Biller B.M., Braunstein G.D., et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003, 138(5):424-429.
12. Barzon L., Scaroni C., Sonino N., et al. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. JClin Endocrinol Metab 1998, 83(1):55-62.
13. Bondanelli M., Campo M., Trasforini G., et al. Evaluation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism 1997, 46(1):107-113.
14. Crucitti F., Bellantone R., Ferrante A., et al. The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery 1996, 119(2):161-170.
15. Eller-Vainicher C., Morelli V., Salcuni A.S., et al. Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma. Eur J Endocrinol 2010, 163(6):925-935.
16. Libè R., Dall'Asta C., Barbetta L., et al. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 2002, 147(4):489-494.
17. Valli N., Catargi B., Ronci N., et al. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 2001, 144(4):401-408.
18. Zeiger M.A., Thompson G.B., Duh Q.Y., et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract 2009, 15(5):450-453.
19. Chiodini I., Losa M., Pavone G., et al. Pregnancy in Cushing's disease shortly after treatment by gamma-knife radiosurgery. JEndocrinol Invest 2004, 27(10):954-956.
20. Chiodini I., Morelli V., Masserini B., et al. Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. JClin Endocrinol Metab 2009, 94(9):3207-3214.
21. Masserini B., Morelli V., Bergamaschi S., et al. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol 2009, 160(1):87-92.
22. Tanabe A., Naruse M., Nishikawa T., et al. Autonomy of cortisol secretion in clinically silent adrenal incidentaloma. Horm Metab Res 2001, 33(7):444-450.
23. Arnaldi G., Angeli A., Atkinson A.B., et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. JClin Endocrinol Metab 2003, 88(12):5593-5602.
24. Nieman L.K., Biller B.M., Findling J.W., et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. JClin Endocrinol Metab 2008, 93(5):1526-1540.
25. Emral R., Uysal A.R., Asik M., et al. Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocr J 2003, 50(4):399-408.
26. Tsagarakis S., Vassiliadi D., Thalassinos N. Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. JEndocrinol Invest 2006, 29(5):471-482.
27. Chiodini I. Clinical review: diagnosis and treatment of subclinical hypercortisolism. JClin Endocrinol Metab 2011, 96(5):1223-1236.
28. Ambrosi B., Peverelli S., Passini E., et al. Abnormalities of endocrine function in patients with clinically "silent" adrenal masses. Eur J Endocrinol 1995, 132(4):422-428.
29. Osella G., Terzolo M., Borretta G., et al. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). JClin Endocrinol Metab 1994, 79(6):1532-1539.
30. Raff H., Findling J.W. Aphysiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 2003, 138(12):980-991.
31. Tsagarakis S., Roboti C., Kokkoris P., et al. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin Endocrinol (Oxf) 1998, 49(2):165-171.
32. Flecchia D., Mazza E., Carlini M., et al. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin Endocrinol (Oxf) 1995, 42(2):129-134.
33. Terzolo M., Osella G., Alì A., et al. Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 1998, 48(1):89-97.
34. Mengden T., Hubmann P., Müller J., et al. Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome. Clin Investig 1992, 70(7):545-548.
35. Carroll B.J., Curtis G.C., Davies B.M., et al. Urinary free cortisol excretion in depression. Psychol Med 1976, 6(1):43-50.
36. Duclos M., Corcuff J.B., Etcheverry N., et al. Abdominal obesity increases overnight cortisol excretion. JEndocrinol Invest 1999, 22(6):465-471.
37. Mericq M.V., Cutler G.B. High fluid intake increases urine free cortisol excretion in normal subjects. JClin Endocrinol Metab 1998, 83(2):682-684.
38. Corcuff J.B., Tabarin A., Rashedi M., et al. Overnight urinary free cortisol determination: a screening test for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 1998, 48(4):503-508.
39. Shiwa T., Oki K., Yamane K., et al. Significantly high level of late-night free cortisol to creatinine ratio in urine specimen in patients with subclinical Cushing's syndrome. Clin Endocrinol (Oxf) 2013, 79:617-622.
40. Kidambi S., Raff H., Findling J.W. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. Eur J Endocrinol 2007, 157(6):725-731.
41. Nunes M.L., Vattaut S., Corcuff J.B., et al. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. JClin Endocrinol Metab 2009, 94(2):456-462.
42. Fekedulegn D., Burchfiel C.M., Violanti J.M., et al. Associations of long-term shift work with waking salivary cortisol concentration and patterns among police officers. Ind Health 2012, 50(6):476-486.
43. Beko G., Varga I., Glaz E., et al. Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin Chim Acta 2010, 411(5-6):364-367.
44. Sereg M., Toke J., Patócs A., et al. Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome. Steroids 2011, 76(1-2):38-42.
45. Morelli V., Masserini B., Salcuni A.S., et al. Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clin Endocrinol (Oxf) 2010, 73(2):161-166.
46. Kasperlik-Zeluska A.A., Rosłonowska E., Słowinska-Srzednicka J., et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 1997, 46(1):29-37.
47. Rossi R., Tauchmanova L., Luciano A., et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. JClin Endocrinol Metab 2000, 85(4):1440-1448.
48. Kloos R.T., Gross M.D., Francis I.R., et al. Incidentally discovered adrenal masses. Endocr Rev 1995, 16(4):460-484.
49. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin Endocrinol (Oxf) 1996, 44(5):587-596.
50. Francis I.R., Gross M.D., Shapiro B., et al. Integrated imaging of adrenal disease. Radiology 1992, 184(1):1-13.
51. Morioka M., Fujii T., Matsuki T., et al. Preclinical Cushing's syndrome: report of seven cases and a review of the literature. Int J Urol 2000, 7(4):126-132.
52. Rizza R.A., Wahner H.W., Spelsberg T.C., et al. Visualization of nonfunctioning adrenal adenomas with iodocholesterol: possible relationship to subcellular distribution of tracer. JNucl Med 1978, 19(5):458-463.
53. Barzon L., Fallo F., Sonino N., et al. Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002, 146(1):61-66.
54. Toniato A., Merante-Boschin I., Opocher G., et al. Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg 2009, 249(3):388-391.
55. Bernini G., Moretti A., Iacconi P., et al. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 2003, 148(2):213-219.
56. Mitchell I.C., Auchus R.J., Juneja K., et al. Subclinical Cushing's syndrome is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 2007, 142(6):900-905. [discussion: 905.e1].
57. Midorikawa S., Sanada H., Hashimoto S., et al. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf) 2001, 54(6):797-804.
58. Aron D.C. The adrenal incidentaloma: disease of modern technology and public health problem. Rev Endocr Metab Disord 2001, 2(3):335-342.
59. Tauchmanovà L., Rossi R., Biondi B., et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. JClin Endocrinol Metab 2002, 87(11):4872-4878.
60. Reincke M., Nieke J., Krestin G.P., et al. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. JClin Endocrinol Metab 1992, 75(3):826-832.
61. Thompson G.B., Grant C.S., van Heerden J.A., et al. Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 1997, 122(6):1132-1136.
62. Korman J.E., Ho T., Hiatt J.R., et al. Comparison of laparoscopic and open adrenalectomy. Am Surg 1997, 63(10):908-912.
63. Constantinides V.A., Christakis I., Touska P., et al. Systematic review and meta-analysis of retroperitoneoscopic versus laparoscopic adrenalectomy. Br J Surg 2012, 99(12):1639-1648.
64. Huiras C.M., Pehling G.B., Caplan R.H. Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. JAMA 1989, 261(6):894-898.
65. Arlt W., Allolio B. Adrenal insufficiency. Lancet 2003, 361(9372):1881-1893.
66. Di Dalmazi G., Vicennati V., Rinaldi E., et al. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur J Endocrinol 2012, 166(4):669-677.
67. Barzon L., Fallo F., Sonino N., et al. Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas. Eur J Endocrinol 2001, 145(2):223-224.
68. Eller-Vainicher C., Morelli V., Salcuni A.S., et al. Post-surgical hypocortisolism afterremoval of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?. Eur J Endocrinol 2010, 162(1):91-99.